Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

COVID-19 Response

Video
11/27/2020
DHA Seal

Army Pfc. David Alvarado, assigned to the Javits New York Medical Station (JNYMS), talks about their position at JNYMS in support of the Department of Defense COVID-19 response, April 24, 2020. U.S. Northern Command, through U.S. Army North, is providing military support to the Federal Emergency Management Agency to help communities in need. (U.S. Army Video by Cpl. Rachel Thicklin.)

Recommended Content:

Coronavirus

Minimize COVID-19 holiday spread with small gatherings, mask wearing

Article
11/25/2020
Soldiers standing in a line, wearing masks

The holiday season is upon us, and so is a drastic rise in coronavirus cases.

Recommended Content:

Coronavirus

NMRTU Everett Hospitalman makes a difference

Article
11/24/2020
Technician wearing a mask, giving a shot to a soldier

For much of 2020, Scott has also done her share and more to help stop the spread of COVID-19.

Recommended Content:

Coronavirus | Public Health

Army conducts commercial aircraft decontamination efficacy test

Article
11/24/2020
Man wearing mask, looking at ceiling of an airplane

Two commercial sprayers and two commercial liquid disinfectants will be tried in different combinations on surfaces in the passenger area to gauge effectiveness.

Recommended Content:

Coronavirus

Navy PA continues to care for COVID-19 caregivers

Article
11/19/2020
Three soldiers, wearing masks, demonstrating a hearing test

As a PAt, Osborn works hand-in-hand with supervising physicians and surgeons.

Recommended Content:

Coronavirus

NICoE & ISC Network maintain TBI care during COVID-19

Article
11/19/2020
Image of United States map with locations noted

The Network leveraged their geographic distribution to help each other quickly adapt to changing times.

Recommended Content:

Coronavirus | Traumatic Brain Injury

San Antonio volunteers sought for Warp Speed vaccine trials

Article
11/18/2020
Woman typing on laptop

DOD sites are open on a voluntary basis to Military Health System beneficiaries.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus

Army combat medic earns U.S. citizenship, plans to continue serving

Article
11/18/2020
Two men wearing masks, one in a car, one leaning in the car

The native of Brazil is part of the COVID-19 testing team.

Recommended Content:

Coronavirus

Army doctors provide COVID-19 safety tips for the holiday season

Article
11/17/2020
Soldiers wearing masks, looking at flight information in airport

Celebrating the holidays during a pandemic may bring additional challenges for people this year.

Recommended Content:

Coronavirus | November Toolkit | November Holidays and Observances

Military Health System participating in COVID-19 vaccine trial

Article
11/17/2020
Woman measuring out a vaccine into a needle

How you can help test the vaccine.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

BACH behavioral health team honored with Army’s Wolf Pack Award

Article
11/17/2020
Military personnel standing in a room, listening to a speaker

The ceremony honored eight individuals and three teams who contributed to exceeding the goal of collecting 10,000 units of COVID-19 convalescent plasma.

Recommended Content:

November Toolkit | Convalescent Plasma Collection Program

DHA leaders recognize CCP collection campaign contributors & donors

Article
11/16/2020
Three military personnel in uniform, wearing masks, in front of flags

The ceremony honored those who contributed to exceeding the goal of collecting 10,000 units of COVID-19 convalescent plasma.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

NMRTU Everett staff collaborate to ensure Patient Centered Care

Article
11/16/2020
Image of two military personnel wearing masks

NMRTU Everett was commended by the MHS 2020 Advancement towards High Reliability Healthcare Awards Program as a Patient Centeredness Award winner.

Recommended Content:

Combat Support | Public Health | Coronavirus

Holiday Season Guidance to Minimize Spread of the Coronavirus Disease 2019

Publication
11/16/2020

This memorandum provides guidance to help protect individuals within the DoD community from coronavirus disease 2019 (COVID-19) for gatherings and activities during the November to January holiday season.

Recommended Content:

Coronavirus

Naval Medical Forces Pacific’s commander tours NH Twentynine Palms

Article
11/12/2020
Four military personnel in uniform, wearing masks

Weber was briefed on the implementation of MHS GENESIS...and the hospital's response to COVID-19.

Recommended Content:

Combat Support | Health Readiness | Coronavirus | MHS GENESIS
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 22

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.